Updated: January 8, 2026
Alternatives to Exparel If You Can't Get It for Your Surgery
Author
Peter Daggett

Summarize with AI
- Option 1: Standard Bupivacaine HCl (Marcaine, Sensorcaine)
- Option 2: Ropivacaine (Naropin)
- Option 3: Continuous Peripheral Nerve Block (Nerve Block Catheters)
- Option 4: XARACOLL (Bupivacaine Collagen Implant)
- Option 5: Multimodal Analgesia Protocols
- Questions to Ask Your Surgeon About Alternatives
- Need Help Finding Your Post-Surgery Prescriptions?
If Exparel isn't available at your hospital or isn't covered by insurance, there are effective alternatives for postoperative pain management. Here's what to know.
Exparel (bupivacaine liposome injectable suspension) is one option for managing pain after surgery — but it's not the only one, and it's not available at every facility. If your hospital doesn't carry it, your insurance won't cover it, or your surgeon prefers a different approach, here are the legitimate alternatives your surgical team might use instead.
The goal of any postoperative analgesia plan is the same: control pain effectively, minimize opioid use, allow you to recover faster, and get you home sooner. Several approaches can accomplish this.
Option 1: Standard Bupivacaine HCl (Marcaine, Sensorcaine)
Standard bupivacaine hydrochloride is the active ingredient in Exparel but without the extended-release liposomal coating. It's an amide local anesthetic that has been used in surgical and regional anesthesia for decades. Generic versions are widely available and cost as little as $2–$8 per vial — a fraction of Exparel's price.
The key difference: standard bupivacaine wears off in 4–8 hours, compared to up to 72 hours for Exparel. For shorter procedures or when adequate multimodal pain management will follow, this shorter duration is often acceptable and effective. Some studies have found that plain bupivacaine used as part of a comprehensive multimodal regimen achieves similar outcomes to Exparel at a much lower cost.
Option 2: Ropivacaine (Naropin)
Ropivacaine is another long-acting amide local anesthetic similar to bupivacaine. It's widely available in generic form and is often used in peripheral nerve blocks, epidurals, and wound infiltration. Ropivacaine has a slightly lower cardiac toxicity profile than bupivacaine, which makes it a preferred choice in some settings, particularly for major nerve blocks where large doses are needed.
Duration is similar to standard bupivacaine — typically 4–12 hours depending on dose and technique. It does not have the extended 72-hour release profile of Exparel, but when combined with other analgesics it can provide effective multiday pain control.
Option 3: Continuous Peripheral Nerve Block (Nerve Block Catheters)
One of the most effective alternatives to Exparel for major surgeries — especially orthopedic procedures — is a continuous peripheral nerve block delivered via a catheter. In this approach, a small catheter is placed near the targeted nerve under ultrasound guidance, and a local anesthetic (usually ropivacaine or plain bupivacaine) is delivered continuously or on demand through the catheter for 1–3 days after surgery.
Advantages include precise pain control and the ability to adjust dosing as needed. The main downside is that catheters require more management and are less practical for patients going home shortly after surgery. In high-volume orthopedic and thoracic programs, continuous nerve blocks are often preferred over single-dose Exparel for complex procedures.
Option 4: XARACOLL (Bupivacaine Collagen Implant)
XARACOLL is another FDA-approved extended-release bupivacaine product, but delivered via a collagen sponge implant rather than a liposomal injection. It's indicated specifically for postoperative pain management in adults following open inguinal hernia repair. Unlike Exparel, it's a solid implant placed directly in the wound at closure.
XARACOLL is a niche product approved for a specific procedure. If you're having inguinal hernia repair and Exparel isn't available, ask your surgeon about XARACOLL as an extended-release alternative.
Option 5: Multimodal Analgesia Protocols
Many surgical teams and Enhanced Recovery After Surgery (ERAS) programs use a multimodal approach that combines multiple non-opioid analgesics to manage postoperative pain:
- Acetaminophen (Tylenol) — given IV during surgery and orally after, provides baseline pain control
- NSAIDs (ketorolac, ibuprofen, celecoxib) — reduce inflammation and pain synergistically with acetaminophen
- Gabapentin or pregabalin — used pre-operatively to reduce pain signaling
- Dexamethasone — reduces swelling and may extend the duration of local anesthetic nerve blocks
- Wound infiltration with plain bupivacaine or ropivacaine — local injection at the surgical site at the time of closure
When used together, these drugs work through different pathways to provide comprehensive pain control. Numerous studies have found that well-designed multimodal protocols achieve pain outcomes comparable to Exparel at a significantly lower cost.
Questions to Ask Your Surgeon About Alternatives
If Exparel isn't an option for your surgery, here are questions to ask your surgical team:
- What is your standard pain management protocol for this procedure?
- Will you use a nerve block, and if so, how long will it last?
- Do you follow an ERAS protocol that minimizes opioid use?
- What non-opioid options will be used for pain control in the first 24–72 hours?
- What oral medications should I expect to be prescribed when I go home?
Need Help Finding Your Post-Surgery Prescriptions?
After surgery, you'll often be sent home with oral pain medications — and sometimes these can be hard to find in stock at pharmacies. medfinder is a paid service that calls pharmacies near you to locate which ones have your prescription in stock. Instead of calling multiple pharmacies yourself while recovering from surgery, medfinder does the searching and texts you the results.
Related reading: Why Is Exparel So Hard to Find? [Explained for 2026].
Also: Exparel Drug Interactions: What to Avoid and What to Tell Your Doctor.
Frequently Asked Questions
There is no single 'best' alternative — it depends on your surgery and your surgical team's expertise. Common alternatives include standard bupivacaine or ropivacaine for wound infiltration, continuous peripheral nerve block catheters for multi-day relief, and multimodal analgesia protocols combining acetaminophen, NSAIDs, and local anesthetics. Ask your surgeon which approach they use routinely.
Standard bupivacaine works through the same mechanism but wears off in 4–8 hours compared to Exparel's up to 72 hours. Some clinical trials have found comparable outcomes when standard bupivacaine is used as part of a well-designed multimodal analgesia protocol. However, for procedures requiring extended postoperative pain control, Exparel's longer duration is a genuine advantage.
No. As of 2026, there is no FDA-approved generic version of Exparel. The DepoFoam liposomal bupivacaine formulation is patented and manufactured exclusively by Pacira BioSciences. Standard bupivacaine HCl is a generic drug but is not equivalent to Exparel.
Ropivacaine can be used for shoulder nerve blocks, but it doesn't have the extended 72-hour release profile of Exparel. For interscalene brachial plexus nerve blocks (the specific FDA-approved indication for Exparel in shoulder surgery), ropivacaine via a continuous catheter can provide comparable multi-day relief, though it requires more management.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Exparel also looked for:
More about Exparel
30,561 have already found their meds with Medfinder.
Start your search today.





